Familial Mediterranean fever (FMF) is an auto-inflammatory disease characterized by relapsing and remitting episodes of fever and serositis. We have a case of a 35-year-old male who presented with nausea, abdominal pain and myalgia for several months. He underwent an extensive workup to rule out diabetic ketoacidosis, celiac disease, gastroparesis, rheumatoid arthritis and porphyria. It was determined that he had heterozygous V726A mutation for the MEFV (Mediterranean fever) gene, suggesting possible FMF. His symptoms responded well to colchicine.
References
[1]
Heberden, W. (2024) Commentaries on the History and Cure of Diseases. BoD-Books on Demand.
[2]
Osler, W. (1895) On the Visceral Manifestations of Erythema Multiforme. The American Journal of the Medical Sciences, 110, 629-646.
[3]
Janeway, T.C. (1908) An Unusual Paroxysmal Syndrome, Probably Allied to Recurrent Vomiting. Archives of Internal Medicine, 2, 214-225. https://doi.org/10.1001/archinte.1908.00050080016002
[4]
Siegal, S. (1945) Benign Paroxysmal Peritonitis. Annals of Internal Medicine, 23, 1-21. https://doi.org/10.7326/0003-4819-23-1-1
[5]
Heller, H. (1958) Familial Mediterranean Fever. Archives of Internal Medicine, 102, 50-71. https://doi.org/10.1001/archinte.1958.00260190052007
[6]
Martinon, F., Burns, K. and Tschopp, J. (2002) The Inflammasome. Molecular Cell, 10, 417-426. https://doi.org/10.1016/s1097-2765(02)00599-3
[7]
Papin, S., Cuenin, S., Agostini, L., Martinon, F., Werner, S., Beer, H., et al. (2007) The SPRY Domain of Pyrin, Mutated in Familial Mediterranean Fever Patients, Interacts with Inflammasome Components and Inhibits Proil-1β Processing. Cell Death & Differentiation, 14, 1457-1466. https://doi.org/10.1038/sj.cdd.4402142
[8]
Touitou, I. (2001) The Spectrum of Familial Mediterranean Fever (FMF) Mutations. European Journal of Human Genetics, 9, 473-483. https://doi.org/10.1038/sj.ejhg.5200658
[9]
Park, Y.H., Wood, G., Kastner, D.L. and Chae, J.J. (2016) Pyrin Inflammasome Activation and Rhoa Signaling in the Autoinflammatory Diseases FMF and HIDS. Nature Immunology, 17, 914-921. https://doi.org/10.1038/ni.3457
[10]
Nobakht, H., Zamani, F., Ajdarkosh, H., Mohamadzadeh, Z., Fereshtehnejad, S. and Nassaji, M. (2011) Adult-Onset Familial Mediterranean Fever in Northwestern Iran: Clinical Feature—A Treatment Outcome. Middle East Journal of Digestive Diseases, 3, 50-55.
[11]
Henderson, C. and Goldbach-Mansky, R. (2010) Monogenic Autoinflammatory Diseases: New Insights into Clinical Aspects and Pathogenesis. Current Opinion in Rheumatology, 22, 567-578. https://doi.org/10.1097/bor.0b013e32833ceff4
[12]
Yalçınkaya, F., Özen, S., Özçakar, Z.B., Aktay, N., Çakar, N., Düzova, A., et al. (2009) A New Set of Criteria for the Diagnosis of Familial Mediterranean Fever in Childhood. Rheumatology, 48, 395-398. https://doi.org/10.1093/rheumatology/ken509
[13]
Gattorno, M., Hofer, M., Federici, S., Vanoni, F., Bovis, F., Aksentijevich, I., et al. (2019) Classification Criteria for Autoinflammatory Recurrent Fevers. Annals of the Rheumatic Diseases, 78, 1025-1032. https://doi.org/10.1136/annrheumdis-2019-215048
[14]
Ozen, S., Demirkaya, E., Erer, B., Livneh, A., Ben-Chetrit, E., Giancane, G., et al. (2016) EULAR Recommendations for the Management of Familial Mediterranean Fever. Annals of the Rheumatic Diseases, 75, 644-651. https://doi.org/10.1136/annrheumdis-2015-208690
